Land Grab At LifeMD

  • Revenue is accelerating and the company’s platform is almost endlessly leverageable with new brands and products.
  • However, as the company is still in the land-grab phase, investments are accelerating even more steeply, and one could argue, worryingly.
  • So losses and dilution are set to continue for quite some time, but if you can see beyond that a pretty attractive picture emerges.
  • The shares trade at a modest EV/S multiple of 5.4.
  • Learn More »